Stomek (also known as A-10, Stamakort, or stomach peptide complex) and Gastrogen (gastric mucin peptide bioregulator) are two natural peptide bioregulators developed in the tradition of Professor Vladimir Khavinson's research. Both are short-chain, low-molecular-weight peptides (typically up to 5,000 Daltons) extracted from the gastric mucosa of young, healthy animals (usually calves under 12 months old). They target cells in the stomach and proximal duodenum, offering tissue-specific support for digestive health. These peptides work by penetrating cells, interacting with DNA in regulatory regions, modulating gene expression, normalizing protein synthesis (including enzymes and mucins), and promoting cellular repair and regeneration. This addresses deficiencies that build up from aging, stress, inflammation, infections (e.g., H. pylori), poor diet, medications, or toxins, helping restore optimal function at an epigenetic-like level. Both are orally bioavailable and act intracellularly without broad systemic effects.

​

Stomek/Stamakort: Broader Gastric Mucosa Support

​

Stomek focuses on the overall metabolism, secretory function, and repair of the gastric mucosa.

​

Key claimed benefits (drawn from Khavinson Institute studies, clinical reports, and user observations):

​

• Normalizes hydrochloric acid production and enzyme activity, helping balance hypo- or hyperacidity for improved digestion of proteins and fats.

• Reduces common symptoms such as heartburn, belching, bloating, heaviness after meals, epigastric pain, and indigestion.

• Supports healing and prevention of erosions, chronic gastritis, gastroduodenitis, peptic ulcers (stomach and duodenal), and atrophic changes.

• Enhances gastric juice composition, secretory and evacuatory functions, and mucosal resistance to damage.

• Promotes better appetite, nutrient absorption, food tolerance, and overall digestive efficiency.

• In a reported clinical study at the St. Petersburg Institute involving patients with chronic gastritis, Stamakort smoothed symptoms in about 86% of cases (with stronger effects in older individuals showing atrophic changes), alongside improvements in endoscopic findings and biochemical markers.

   

Stamakort is often recommended for prevention and remission maintenance in stomach-related disorders, especially those linked to improper diet, stress, or medication use.

​

Gastrogen: Targeted Gastric Mucin and Barrier Support

​

Gastrogen specifically targets mucin-producing cells (goblet and mucous neck cells) and the protective mucus layer of the stomach.

​

Key claimed benefits (from product descriptions and aligned Khavinson principles):

​

• Strengthens and optimizes the gastric mucus barrier—the essential protective coating that shields the stomach lining from acid, pepsin, irritants, pathogens, alcohol, NSAIDs, and stress.

• Supports mucin production and quality (e.g., key mucins like MUC5AC and MUC6), enhancing structural integrity and reducing vulnerability to erosion or inflammation.

• Provides nutritional signaling to maintain peptide homeostasis in the mucosa, aiding in the prevention or management of conditions involving mucus compromise (e.g., erosive gastritis, acid reflux, or ulcer predisposition).

• Complements broader gastric repair by focusing on the "first line of defense," helping preserve mucosal health even under challenging conditions.

 

While there's overlap with Stamakort (both originate from gastric mucosa extracts), Gastrogen emphasizes the mucus shield aspect, making it more specialized for barrier reinforcement.

​

Synergy Between Stamakort and Gastrogen

​

Together, these peptides provide comprehensive upper GI support: Stamakort handles metabolic and secretory restoration (acid/enzyme balance, cell function, symptom relief), while Gastrogen fortifies the protective mucus layer. This dual action enhances overall mucosal defense, repair, and resilience—potentially more effective for addressing irritation, barrier weakness, or inconsistent digestion than either alone.

​

Relevance to Gut Health Protocols

​

In contexts like gut balancing (e.g., addressing dysbiosis, leaky gut, food sensitivities, or inflammation), strong stomach function is foundational. Upstream issues in the stomach can impair protein/fat breakdown, increase fermentable load (fueling microbiome imbalances), or allow irritants to pass systemically. These peptides support:

​

• Rebuilding mucosal integrity and barrier strength to reduce inflammation and permeability concerns.

• Normalizing digestion to improve nutrient uptake and decrease undigested material that disrupts the microbiome.

• Easing symptoms that interfere with interventions like probiotics, antimicrobials, or dietary changes.

 

Evidence comes primarily from Russian-origin research (e.g., Khavinson Institute trials on gastritis and ulcers), animal models, and clinical/anecdotal observations rather than large-scale Western randomized controlled trials. These are dietary supplements, generally well-tolerated with minimal reported side effects, but individual responses vary. Consult a healthcare provider experienced in functional or peptide-based approaches before use. They are not a standalone treatment for any condition.